Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Patients With Limb Girdle and Facioscapulohumeral Muscular Dystrophy

Conditions: Facioscapulohumeral Muscular Dystrophy; Limb Girdle Muscular DystrophyIntervention: Drug: ATYR1940Sponsor: aTyr Pharma, Inc.Enrolling by invitation - verified July 2016

http://clinicaltrials.gov/ct2/show/NCT02836418?lup_s=06%2F19%2F2016&lup_d=30

Source: ClinicalTrials.gov - June 30, 2016 Category: Research Source Type: clinical trials